A relaxin-based nanotherapy for liver fibrosis

Nat Nanotechnol. 2021 Apr;16(4):365-366. doi: 10.1038/s41565-020-00832-w.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Liver Cirrhosis / drug therapy
  • Relaxin* / therapeutic use

Substances

  • Relaxin